Ads
related to: regn stock quote
Search results
Those who invested in Regeneron Pharmaceuticals (NASDAQ:REGN) five years ago are up 88%
Simply Wall St. via Yahoo Finance· 11 months agoStock pickers are generally looking for stocks that will outperform the broader market. And while...
Regeneron (REGN) Stock Rallies 10% YTD: What Lies Ahead?
Zacks via Yahoo Finance· 7 months agoShares of Regeneron REGN have gained 10.3% year to date against the industry’s decline of 14.8%....
Regeneron (REGN) Gets CRL for Aflibercept 8 mg Drug, Shares Fall
Zacks via Yahoo Finance· 12 months agoRegeneron (REGN) receives a completed response letter for the application seeking approval of...
Investing in Regeneron Pharmaceuticals (NASDAQ:REGN) five years ago would have delivered you a 118%...
Simply Wall St. via Yahoo Finance· 9 months agoThe most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on...
Regeneron Pharmaceuticals' (NASDAQ:REGN) five-year earnings growth trails the splendid shareholder...
Simply Wall St. via Yahoo Finance· 6 months agoWhen you buy a stock there is always a possibility that it could drop 100%. But when you pick a...
Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA
Zacks via Yahoo Finance· 3 months agoRegeneron Pharmaceuticals, Inc. REGN suffered a setback as the FDA issued Complete Response Letters...
What is in Store for Regeneron (REGN) This Earnings Season?
Zacks via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals, Inc. REGN is scheduled to release second-quarter 2022 results on Aug 3,...
Regeneron Pharmaceuticals' (NASDAQ:REGN) investors will be pleased with their solid 158% return over...
Simply Wall St. via Yahoo Finance· 1 year agoWhen you buy a stock there is always a possibility that it could drop 100%. But on the bright side,...
Is a Beat on the Cards for Regeneron's (REGN) Q1 Earnings?
Zacks via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. REGN is scheduled to release first-quarter 2023 results on May 4,...
Drug, Biotech Stocks' Q3 Earnings on Nov 3: AMGN, REGN & More
Zacks via Yahoo Finance· 2 years agoThe earnings season is in full swing for the drug/biotech sector. Overall, it has been a mixed...